Vorolanib + Atezolizumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

NCT04373369 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

11

Enrollment

OTHER

Sponsor class

Stopped Insufficient Funding/Staff

Conditions

Extensive-stage Small Cell Lung Cancer

Interventions

DRUG: Vorolanib
DRUG: Atezolizumab

Sponsor

Washington University School of Medicine

Collaborators

[object Object]